Walleye Trading LLC Crispr Therapeutics Ag Call Options Transaction History

Walleye Trading LLC

  • $41.2 Billion
  • Q2 2024

Call Options

24 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$51.17 - $68.18 $1.19 Million - $1.58 Million
-23,200 Reduced 43.28%
30,400 $1.64 Million
Q1 2024

May 15, 2024
SELL
$60.67 - $89.12 $3.57 Million - $5.24 Million
-58,800 Reduced 52.31%
53,600 $3.65 Million
Q4 2023

Feb 14, 2024
SELL
$38.62 - $72.18 $142,894 - $267,066
-3,700 Reduced 3.19%
112,400 $7.04 Million
Q3 2023

Nov 14, 2023
SELL
$45.39 - $59.0 $1.53 Million - $1.99 Million
-33,800 Reduced 22.55%
116,100 $5.27 Million
Q2 2023

Aug 14, 2023
SELL
$43.47 - $67.77 $2.54 Million - $3.96 Million
-58,500 Reduced 28.07%
149,900 $8.42 Million
Q1 2023

May 15, 2023
SELL
$41.0 - $56.12 $4.69 Million - $6.43 Million
-114,500 Reduced 35.46%
208,400 $9.43 Million
Q4 2022

Feb 14, 2023
BUY
$39.19 - $65.67 $940,560 - $1.58 Million
24,000 Added 8.03%
322,900 $13.1 Million
Q3 2022

Nov 14, 2022
BUY
$61.1 - $83.78 $8 Million - $11 Million
131,000 Added 78.02%
298,900 $19.5 Million
Q2 2022

Aug 08, 2022
BUY
$43.23 - $73.83 $1.15 Million - $1.97 Million
26,700 Added 18.91%
167,900 $10.2 Million
Q1 2022

May 16, 2022
BUY
$53.19 - $79.24 $4.92 Million - $7.33 Million
92,500 Added 189.94%
141,200 $8.86 Million
Q4 2021

Feb 14, 2022
SELL
$70.09 - $111.29 $939,206 - $1.49 Million
-13,400 Reduced 21.58%
48,700 $3.69 Million
Q3 2021

Nov 15, 2021
BUY
$110.2 - $156.64 $1.01 Million - $1.44 Million
9,200 Added 17.39%
62,100 $6.95 Million
Q2 2021

Aug 16, 2021
SELL
$100.84 - $161.89 $242,016 - $388,535
-2,400 Reduced 4.34%
52,900 $8.56 Million
Q1 2021

May 17, 2021
BUY
$110.72 - $210.04 $4.54 Million - $8.61 Million
41,000 Added 286.71%
55,300 $6.74 Million
Q4 2020

Feb 16, 2021
BUY
$79.67 - $173.23 $191,208 - $415,752
2,400 Added 20.17%
14,300 $2.19 Million
Q3 2020

Nov 16, 2020
BUY
$78.5 - $100.64 $23,550 - $30,192
300 Added 2.59%
11,900 $995,000
Q2 2020

Aug 14, 2020
SELL
$38.5 - $76.05 $323,400 - $638,820
-8,400 Reduced 42.0%
11,600 $852,000
Q1 2020

May 15, 2020
SELL
$33.68 - $62.53 $872,312 - $1.62 Million
-25,900 Reduced 56.43%
20,000 $848,000
Q4 2019

Feb 14, 2020
BUY
$36.68 - $73.13 $1.14 Million - $2.27 Million
31,000 Added 208.05%
45,900 $2.8 Million
Q3 2019

Nov 14, 2019
SELL
$40.99 - $52.56 $1.11 Million - $1.43 Million
-27,200 Reduced 64.61%
14,900 $611,000
Q2 2019

Aug 14, 2019
BUY
$35.45 - $48.2 $1.29 Million - $1.75 Million
36,300 Added 625.86%
42,100 $1.98 Million
Q1 2019

May 15, 2019
SELL
$28.02 - $40.87 $563,202 - $821,487
-20,100 Reduced 77.61%
5,800 $207,000
Q4 2018

Feb 14, 2019
BUY
$22.73 - $42.34 $520,517 - $969,586
22,900 Added 763.33%
25,900 $740,000
Q3 2018

Nov 14, 2018
BUY
$44.35 - $65.71 $133,050 - $197,129
3,000 New
3,000 $133,000

Others Institutions Holding CRSP

# of Institutions
503
Shares Held
57M
Call Options Held
1.7M
Put Options Held
1.8M
View Full List

About CRISPR Therapeutics AG

CRSP Quotes by TradingView
  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $4.03B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email